The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma

The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma - The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041054

Enrollment

Registered

2020-07-09

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral carcinoma

Interventions

PDT with talaporfin sodium

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: tumor size> 6cm tumor thickness < 5mm no metastasis

Exclusion criteria

Exclusion criteria: metastasis treatment term >2 hours

Design outcomes

Primary

Measure	Time frame
Histopathological finding 6 weeks after treatment	—

Countries

Japan

Contacts

Public ContactHisazumi Ikeda

Sasebo General Hospital Dentistry

hisazumi0115@gmail.com0956-24-1515

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026